Towards Establishment of an Ex Vivo Bladder Tumor Model using Precision Cut Tumor Slices (PCTS) for Evaluation of Existing and Novel Treatments
To continue the development of novel therapeutics to treat bladder cancer, a reliable model for preclinical testing of treatments and studying of the disease mechanism is essential. Ex vivo culturing of precision cut tumor slices (PCTS) provides a model that can retain the tumor architecture and its tumor microenvironment including the immune cell compartment, but data on PCTS based on bladder tum
